D
uring thymic development, T cells mature from a CD4/ CD8 double negative (DN) 3 via the CD4/CD8 double positive (DP) stage to either CD4 or CD8 single positive (SP) cells. By using CD25 and CD44, the DN stage can be further subdivided into four consecutive populations, which are termed DN1-DN4 (1) . V(D)J rearrangements of the TCR␤, ␥, and ␦ loci start in DN2 and are completed in DN3 (2) . To survive in the DN4 and mature to the DP stage, ␣␤ T cells are subjected to ␤-selection, a process that is critically depended upon signaling by the pre-TCR and ensures that only cells with a functionally rearranged TCR␤ gene proceed in development (3) . T cell development in animals with deficiencies in pre-TCR signaling is blocked at the DN3 stage (4 -8) . Cross-linking CD3⑀ via anti-CD3⑀ Abs (9) can overcome the block in pre-TCR-deficient animals and produce a single wave of DP cells. Development of ␥␦ T cells does not depend on a pre-TCR, and the ␥␦ TCR is expressed only after the cells have reached the DN4 stage (6, 10 -12) .
At least two types of regulatory elements are involved in the control of transcription and accessibility for recombination of the TCR␤ locus. V␤ promoters initiate germline transcription of the individual V␤ segments, but their role in V␤3 D␤J␤ rearrangements remains controversial. Experiments using transgenic (tg) mice carrying a TCR␤ minilocus in which the decamer sequence of the V␤8.3 promoter was mutated (13) suggested that the promoter is necessary for the expression but not for the rearrangement of V␤ segments. However, this study could not exclude the possibility that the promoter of the upstream V␤5.2 segment had facilitated the accessibility to the recombination machinery. A more recent report (14) showed that the knockout of the V␤13.1 promoter reduced the usage of the V␤13.1 segment in V␤3 D␤J␤ rearrangements 5-to 10-fold but lead to complete lack of V␤13.1 ϩ T cells in the periphery. Unexpectedly, these knockout mice showed germline transcripts of V␤13.1, which were initiated by previously uncharacterized sequences upstream of the deleted promoter region. Taken together, both studies show that the V␤ promoter is crucial for expression of rearranged TCR␤ genes, but the requirement for the promoter and promoter-depended germline transcription in V␤3 D␤J␤ rearrangements remains uncertain.
The element that has been studied best is the E␤ enhancer, a 0.5-kB segment that is located 6 kb 3Ј of C␤2 exon 4 (15, 16) . Absence of E␤ results in hypermethylation and histone H3 hypoacetylation of the D␤J␤1/D␤J␤2 region and a lack of D␤J␤1/ D␤J␤2 germline transcripts (17) . These changes seem to be confined to the DJC region of the TCR␤ locus because the same study could not detect alterations in epigenetic modifications or in germline transcription of the V␤5.2 and V␤14.1 segments. Recently, it has been shown for the germline promoter pD␤1 that the basal transcriptional machinery is still recruited in the absence of E␤ but that E␤ is required for subtle changes in the chromatin structure that seem to be required for activation of transcription (18) . E␤ is capable of mediating tissue and developmental stage-specific V␤3 D␤J␤ rearrangements of a TCR␤ minilocus in vivo (19, 20) . E␤ Ϫ/Ϫ mice do not show V␤3 D␤J␤ rearrangements (21, 22) and present a phenotype similar to that of TCR␤ Ϫ/Ϫ animals (23). Several studies have addressed the question of germline transcription of V␤ genes in the presence (24, 25) and absence (17, 26, 27) of E␤. Using Rag Ϫ/Ϫ and anti-CD3⑀-induced Rag Ϫ/Ϫ mice as a source of DN and DP cells, respectively, these reports showed that V␤ germline transcription is independent of E␤, prominent in the DN population, and down-regulated to a certain extend (4-to 5-fold with the exception of V␤14.1 (25) ) upon induction of DP cells. No experiments have so far been done to characterize the role of E␤ in the expression of rearranged TCR␤ genes in thymic subpopulations.
In the present study, we used a bacterial artificial chromosome (BAC), encoding a functionally rearranged TCR␤ gene plus reporter (V␤8.2D␤1J␤1.3C␤1-IRES-eGFP) in the genomic context of a TCR␤ locus lacking the E␤ enhancer. We show that expression of the TCR␤ transgene is confined to the DN2/DN3 populations but nevertheless induces all developmental effects ascribed to a functional pre-TCR (␤-selection, TCR␤ allelic exclusion, inhibition of ␥␦ T cell development).
Materials and Methods

BAC modification and sequencing
The construction of the initial TCR␤ BAC encoding the HY-TCR␤-chain has been described elsewhere (28) . Insertion of a 10.2-kb DNA fragment encoding for D␤1J␤1.3-C␤1-IRES-eGFP-D␤2-J␤2.3 into this TCR␤ BAC was done via the pSV1 shuttle vector system as described in Ref. 29 . The IRES-eGFP cassette was a gift from Dr. R. Ketteler (Max-Planck-Institute of Immunobiology, Freiburg, Germany). PstI restriction digest and Southern blotting were used to confirm correct integration. PFGE was performed using the CHEF Mapper XA system (Bio-Rad) with the following parameters: buffer, 0.5ϫ Tris-borate EDTA; temperature, 14°C; gel, 0.8% NEEO agarose (Roth); electrophoresis, 6 V/cm, 120°included angle, 17:32 h running time, switch interval 0.3-15.51 s, linear ramping. TOPO Shotgun Subcloning kit (Invitrogen Life Technologies) was used to subclone the BAC. Subclones (384) were sequenced, yielding 63% coverage of the BAC. The following primers were used to detect either the wild-type (WT) or the ⌬E␤ locus: CACTTTAAGAACCACGCCTGC (common 5Ј), TTA CAGTGCTTGATAGTTATTACC (WT 3Ј), and AGGCACATAA GAGGATGCTGG (⌬E␤ 3Ј).
Mice and transgenesis
The BAC was linearized by NotI digestion before injection. PFGE was used to confirm that the DNA was not degraded. Pronuclear injections were performed in the transgenic facility of the Max-Planck-Institute. Unless otherwise mentioned, experiments were done with mice on a FVB/N background. The mice used in the TCR␤ null experiment had been backcrossed to C57BL/6 for four generations (N4). Mice were genotyped by PCR, using the following primers for eGFP (BAC transgene) or TCR␤ WT and null (30) allele: CGGCATCAAGGCCAACTTCAAGAG (GFP 5Ј), CTTGTA CAGCTCGTCCATGCCGAG (GFP 3Ј), AGGGACCAGGCTTTTGGTA ATAGG (J␤1.2), GGCTTCCTTCTCCAAAA TAGAGCG (J␤1.3), and GCCTTCTATCGCCTTCTTGACGAG (Neo 3Ј end). Primers used for TCR␤ WT/KO genotyping were specific for the respective alleles and did not recognize the transgene. All mice were housed in a conventional unit of the Max-Planck-Institute animal facility and were used at 5-7 wk of age.
FACS stainings
Blocking of FcRs was done by incubating single-cell suspensions with 2.4G2 hybridoma supernatant before the staining procedure. The following mAbs were used for flow cytometry (all from BD Pharmingen): anti-CD4-biotin (H129.19), anti-CD4-PerCP (RM4-5), anti-CD8-biotin (53-6.7), anti-CD25-biotin (7D4), anti-CD25-PE-Cy7 (PC61), anti-CD44-biotin (IM7), anti-CD161c-biotin (PK136), anti-TCR␤-APC (H57-597), anti-TCR␦-PE (GL3), anti-V␤4-PE (KT4), and anti-V␤8.1/2-PE (MR5-2). The Alexa647 (Molecular Probes) labeled anti-V␤8.2 (F23.2) mAb was a kind gift from Dr. J. Kirberg (Max-Planck-Institute of Immunobiology). Second-step staining of biotinylated mAbs was done using streptavidin-PerCP or streptavidin-APC-Cy7 (BD Pharmingen). Apoptosis was measured with the annexin V-FITC Apoptosis Detection Kit I (BD Pharmingen). For intracellular (i.c.) staining, cells were fixed with 1% paraformaldehyde (3 h at 4°C) and permeabilized with 0.25% saponin (20 min). After permeabilization, all subsequent steps were done in PBS/FCS (2%) containing 0.1% saponin. To rule out unspecific binding of fluorophore-conjugated mAbs to i.c. structures, controls were incubated with 5 g of purified H57-597 or GL3 mAb during permeabilization. Cells were analyzed on a FACSCalibur or LSRII (BD Biosciences) flow cytometer and the data was evaluated using CellQuest, FACSDiVa (BD Biosciences) or FlowJo (Tree Star). For sorting of DN thymocytes, cell suspensions were first depleted of CD4 ϩ and CD8 ϩ cells by MACS (Miltenyi Biotec) and afterward sorted on a MoFlo cell sorter (DakoCytomation).
Reaggregated thymic organs cultures (RTOCs)
RTOCs were done according to Ref. 31 . Briefly, fetal thymic lobes were taken from E15.5 BALB/c embryos and treated with 1.35 mM deoxyguanosine (Sigma-Aldrich) for 6 days. Lobes were then disaggregated with trypsin/EDTA (PAA). A total of 1 ϫ 10 6 thymic stroma cells was mixed with thymocytes from tg mice and reaggregated on polycarbonate filters (Nuclepore 0.8 m; Whatman), floating on IMDM ϩ FCS (10%) ϩ Lglutamine (4 mM) ϩ kanamycin (100 g/ml) ϩ 2-ME (35 M). RTOCs were cultured for the indicated time periods at 37°C and 7% CO 2 .
VDJ rearrangement PCR
Genomic DNA from 1 ϫ 10 5 sorted thymocytes was prepared by proteinase K digestion of the cells followed by isopropanol precipitation. The amount of DNA used in the experiments was adjusted according to serial dilution PCR using insulin-specific primers. The VDJ rearrangement PCRs were done using the following primers: AGCTGTCTCCTACTATC GATTTCC (3Ј of J␤2.6), GATATGCGAACAGTATCTAGGCCA (V␤4), and TGTA CTGGTACCGACAGGATTCAG (V␤6). The following program was used for amplification: 94°C/2 h; (94°C/30 min; 68°C/40 min; 72°C/2 h) ϫ 40; 72°C/7 h.
RT-PCR analysis
RNA from sorted thymocytes was isolated using TRI Reagent (SigmaAldrich) and afterward subjected to DNase treatment (DNA-Free; Ambion). Reverse transcription with oligo(dT) primers used SuperScriptII RNaseH Ϫ (Invitrogen Life Technologies). The following primers were used to amplify the full length V␤8.2 cDNA: ATGGGCTCCAGGCTCT TCTTCGTG (V␤8.2 exon 1) and GATCTGGCTTCATGAATTCTT TCTTTTGAC (C␤1 exon 4 ϩ linker). The purification and cloning of the PCR product was done using the TOPO-XL PCR cloning kit (Invitrogen Life Technologies).
Results
A TCR␤ BAC lacking the E␤ enhancer
To assess the ␤-selection potential of different V␤D␤J␤ joints we created a BAC coding for the HY-TCR␤-chain in the genomic context of the TCR␤ locus (Fig. 1a ). An exact description of the BAC has been published elsewhere (28) . By homologous recombination, the existing V␤8.2D␤2J␤2.3 joint was replaced by a 10.2-kb fragment containing the following elements: the joint to be tested (V␤8.2D␤1J␤1.3), J␤1.4-C␤1, an IRES-eGFP reporter placed directly behind the stop codon of C␤1 exon 4, D␤2, and J␤2.1-J␤2.3. PFGE of a BAC clone in which the targeting procedure had been successful suggested that a deletion had occurred because the NotI-linearized BAC was ϳ50 kb shorter than expected. Additional digests (Fig. 1b ) confirmed this and hinted that a deletion had occurred in the 3Ј region of the BAC. Shotgun sequencing of 384 clones derived from this BAC yielded 3 clones spanning a deletion, starting at 4.8 kb 3Ј of the C␤2 stop codon (1.1 kb 5Ј of the E␤ HpaI site) and extending 44.6 kb downstream. PCR using a pair of primers, which were located 5Ј and 3Ј of the deletion, yielded a product when the ⌬E␤ BAC was used as template but not with a BAC containing the 3Ј part of the germline TCR␤ locus. Conversely, a PCR in which the 3Ј primer was replaced with a primer located in the very 5Ј part of the deletion yielded a product with the germline but not with the ⌬E␤ BAC used as a template (Fig. 1c) .
Mice carrying the complete original BAC showed normal expression of the TCR␤ transgene during thymic development and in the periphery (28) . Realizing that our ⌬E␤ BAC should enable us to monitor TCR␤ tg expression driven by the V␤8.2 promoter alone, we decided to generate mice that carried this BAC as a transgene. For pronuclei injections, we used the FVB/N mouse strain because it carries the TCR␤ a allele (32), which contains a large deletion in the V␤ region, encompassing-among other V␤s-V␤8. Two founder animals were obtained whose offspring showed very similar phenotypes. Therefore, the results of only one of the lines are shown below. RT-PCR analysis of DN3 thymocytes of tg mice revealed a full-length V␤8.2-C␤1 transcript (Fig.  1d) . Cloning of the PCR product and sequencing of four of these clones confirmed the specificity of the PCR and did not reveal any consistent mutations at the cDNA level (data not shown).
Thymic expression pattern of the ⌬E␤ BAC transgene
When compared with WT littermates, tg animals showed a ϳ4-fold decrease in thymic cellularity with a slight increase in the percentage of DP thymocytes (Tab 1). The absolute number of CD4 SP thymocytes was decreased ϳ10-fold. Although the percentage of CD8 SP thymocytes was not changed significantly, their absolute number was also ϳ4-fold decreased. Cells accumulated in the TCR␤ low CD69 Ϫ stage, while the number of CD69 ϩ thymocytes was reduced substantially. The percentage of TCR␤ high thymocytes was significantly reduced (3-fold) in comparison to WT animals. These results are consistent with an incomplete block in the DP population somewhat before positive selection. As some of the CD8 SP cells belong to the immature SP (ISP) subset, a less pronounced reduction than that of CD4 cells is in agreement with this hypothesis.
As FVB/N mice do not possess endogenous V␤8 genes, we could use anti-V␤8.1/8.2 or anti-V␤8.2 mAbs to specifically stain the TCR␤-chain encoded by the transgene. In the thymi of tg mice, we were unable to detect any cells, which expressed V␤8.1/8.2 on the cell surface (Table I ). The pre-TCR is expressed in the DN and the CD8 ISP stages of T cell development and occurs in very low abundance on the cell surface (33) . Thus, because expression of the V␤8.2 transgene in the context of the pre-TCR would have escaped the detection by surface staining, we used i.c. stainings. By this means, we detected transgene expression in the majority of DN2 cells and in some DN3 cells but not in DN4 cells and further developed thymocytes of tg mice (Fig. 2, a and b) . Over 85% of the gated V␤8.1/8.2 ic ϩ eGFP ϩ population were found to be CD4 Ϫ CD8 Ϫ CD161c Ϫ CD25 ϩ , consistent with transgene expression predominantly in DN2/DN3 (Fig. 2c) . TCR␤ ic ϩ V␤8.1/8.2 ic Ϫ cells, i.e., cells expressing endogenous TCR␤-chains, were detected in DN3 and DN4 cells, in ϳ10% of DP cells, and in ϳ50% of SP cells (Fig. 2, a and b) . Intriguingly, the vast majority of DP cells and ϳ50% of SP cells (predominantly CD4 SP cells; data not shown) expressed no i.c. TCR␤-chains at all (Fig. 2a) . These results suggested that the TCR␤ tg, while being expressed only in DN2/DN3, inhibited the generation of cells expressing endogenous . c, PCR with primers either specific for the ⌬E␤ (del) or the unmodified (WT) TCR␤ locus was performed using either the BAC containing the 44-kB E␤ deletion (⌬E␤) or a BAC containing the 3Ј part of the germline TCR␤ locus (GL) as template. d, DN3 thymocytes of tg mice were sorted, and total RNA was isolated. RT-PCR was performed using primers recognizing V␤8.2 exon 1 and C␤1 exon 4 (M, marker; ϩ, ϩRT; Ϫ, ϪRT). TCR␤-chains but nevertheless permitted a certain degree maturation of thymocytes that did not express TCR␤. TCR␤ transgenes have been shown to inhibit ␥␦ T cell lineage development, in part due to inhibition of endogenous TCR␥ gene rearrangements (12, 34) . To analyze whether this effect was also associated with a TCR␤ tg whose expression is restricted to DN2/ DN3, we analyzed i.c. TCR␤ vs TCR␦ proteins in the DN4 population of tg and WT mice (Fig. 2d) . The percentage of TCR␦ ic ϩ cells was severely (Ͼ15-fold) reduced in comparison to WT littermates. The results suggest that the TCR␤ tg, despite its restricted expression in DN2/DN3, is capable of inhibiting ␥␦ T cell lineage development.
Down-regulation of the TCR␤ transgene during the DN3 stage in tg mice
The DN2/DN3 restricted expression pattern could be due either to down-regulation of transgene expression or to death of transgene expressing cells in DN3. To distinguish between these possibilities, we sorted GFP ϩ and GFP Ϫ DN3 cells of tg mice and placed them into reaggregate thymic organ cultures (RTOCs). Approximately 50% of the input GFP ϩ DN3 cells were V␤8.1/8.2 ic ϩ (data not shown; see Fig. 2c ). Analyses of cultures of GFP ϩ cells showed that already at day 2 the percentage of V␤8.1/8.2 ic ϩ DN3 cells had dropped to 12%, indicating that Ͼ70% of the V␤8.1/ 8.2 ic ϩ DN3 cells had stopped transgene expression (Fig. 3) . This became even more obvious at days 4 and 7, when only ϳ1.7 and 1%, respectively, of all DN3/DN4 cells where still V␤8.1/8.2 ic ϩ . The data also show that the TCR␤ tg is down-regulated before CD25, i.e., while the cells are still in DN3. In contrast to the GFP ϩ cells, progeny of the GFP Ϫ cells expressed the transgene neither at day 2 nor at day 7. Importantly, the proportions of DN4 cells derived from GFP Ϫ and from GFP ϩ DN3 cells were similar, suggesting that transgene expression is not toxic for the cells. The greater total cell number derived from GFP Ϫ DN3 cells appears to be due to a more efficient production of DP cells. 
No increased apoptosis in DN3/DN4 cells of tg mice
To further address the putative toxicity of the transgene, we analyzed the proportions of apoptotic cells in DN3 and DN4 cells of tg and WT mice. Apoptosis of thymocytes that fail to pass ␤-selection takes place in DN4 (11). Because we found a substantial increase of TCR␤ ic Ϫ TCR␦ ic Ϫ cells in this population of tg mice (Fig. 2c) , it was possible that these cells, due to down-regulation of the transgene, could have failed ␤-selection and become apoptotic. To address this question, we used annexin V/propidium iodide (PI) double stainings, allowing to distinguish early apoptotic (annexin V ϩ PI Ϫ from late apoptotic (annexin V ϩ PI ϩ ) and necrotic (annexin V Ϫ PI ϩ ) cells (Fig. 4) . Because we had to use FITC-conjugated annexin, the annexin signal of the viable DN3 population of tg animals includes the GFP fluorescence and is therefore brighter than that of WT DN3 cells. In DN4 cells, this effect is less pronounced, in line with the shutdown of transgene expression in this population. Nevertheless, annexin V ϩ early apoptotic cells could be clearly distinguished from annexin V Ϫ viable cells. In agreement with our previous observations (11) , only negligible numbers of apoptotic cells were seen in the DN3 subsets of both tg and WT mice, whereas the DN4 subsets of both types of mice contained significant numbers of apoptotic cells. No significant difference in the percentages of early apoptotic cells were seen in DN4, whereas the percentage of late apoptotic cells was lower in tg mice than in WT animals (20.4 vs 36.1%), a phenomenon that could be attributed to the enlarged population of ␤-selected DN4 cells in tg animals (see Discussion). The results suggest that transgene expression is not associated with an increase of apoptotic cells in the DN3/DN4 populations of tg mice.
Inhibition of endogenous TCR␤ locus rearrangements in tg mice
TCR␤ transgenes usually inhibit endogenous TCR␤ rearrangements, a phenomenon reflecting TCR␤ locus allelic exclusion. We determined endogenous TCR␤ rearrangements at the DNA and protein levels. For DNA analyses, V␤8.1/8.2 ic ϩ and V␤8.1/8.2 ic Ϫ DN3 cells of tg mice were sorted, and TCR␤ VDJ rearrangements were assayed by semiquantitative PCR using primers for V␤4.1 and V␤6.1, which are located 5Ј and 3Ј, respectively, of the deletion in the TCR␤ a allele (32) (Fig. 5a ). Sorted DN3 cells of WT littermates and splenocytes of Rag-2 Ϫ/Ϫ mice were used as controls. This experiment showed clearly that rearrangements of the endogenous loci were drastically, albeit not completely, suppressed in the DN3 population of tg mice. Of note, no differences were seen in the extent of inhibition of rearrangements between V␤8.1/8.2 ic ϩ and V␤8.1/8.2 ic Ϫ cells, indicating that the latter subset had passed through a phase of transgene expression as well. For analyses at the protein level, we monitored expression of V␤8.2 and V␤4.1 in DN3 and DN4 by FACS analysis (Fig. 5b) . Although ϳ10% of all TCR␤ ic ϩ DN3 and DN4 cells in WT mice are V␤4.1 ic ϩ , no V␤4.1 ic ϩ DN3 cells and only a few V␤4.1 ic ϩ DN4 cells (ϳ5% of WT) could be detected in tg animals. Nevertheless, we observed a population of TCR␤ ic ϩ V␤8.1/8.2 ic Ϫ cells in the DN4 subset, obviously expressing endogenous TCR␤ rearrangements. This population is ϳ5-fold reduced compared with WT mice, which is consistent with the assumption that a small number of endogenous TCR␤ genes rearrange in DN3 and are expanded by ␤-selection in DN4. Taken together, these experiments show that the ⌬E␤ transgene is capable of mediating allelic exclusion, similar to other TCR␤ transgenes (35) .
␤-Selection on a TCR␤-deficient background
Several of the experiments described above indicated that the DN2/DN3-restricted TCR␤ tg was nevertheless capable of inducing ␤-selection. For example, the TCR␤ ic Ϫ TCR␦ ic Ϫ subset of DN4, usually containing apoptotic cells that had failed ␤-selection 
FIGURE 4.
Apoptosis is not substantially altered in tg mice. Thymocytes from WT and tg mice were stained with mAbs against CD4, CD8, CD25, CD44, and CD161c. Subsequently, the cells were labeled with Annexin V/PI and analyzed by flow cytometry. Because annexin V-FITC and eGFP are detected on the same fluorescence channel, the DN3 population from tg animals is shifted toward the right.
(11), was drastically increased in tg mice without showing increased numbers of apoptotic cells (see Figs. 2b and 5) . Moreover, as shown in Fig. 2b , the CD25 expression pattern in the tg mice revealed a large population with intermediate expression, which was not seen in WT mice. This population could represent DN3 cells that prematurely down-regulated CD25 as a result of ␤-selection by the TCR␤ tg. To definitively clarify this point, we crossed the TCR␤ tg mice with TCR␤ knockout mice. In comparison with TCR␤ Ϫ/Ϫ tg Ϫ mice, TCR␤ Ϫ/Ϫ tg ϩ animals presented an ϳ3-fold increase in the number of total thymocytes (Fig. 6) . FACS analysis showed that this increase was mainly due to an expansion of the DP population (76 vs 11%), corresponding to a Ͼ20-fold increase in absolute numbers of DP cells. In addition, increased numbers of both types of SP cells were observed. The results suggest that the TCR␤ tg was capable of partially restoring the generation of DP cells, which is severely compromised in TCR␤ Ϫ/Ϫ tg Ϫ animals. Interestingly, as in all previous experiments, no significant expression of V␤8.1/8.2 (Ͻ1% of the cells) could be detected beyond the DN3 stage (data not shown). These data suggest that the transgene in fact is able to mediate ␤-selection and perhaps some further maturation as well.
Discussion
In this report, we describe a ⌬E␤ TCR␤ BAC tg mouse that shows a DN2/DN3-restricted expression pattern of the transgene. The restricted expression is likely due to the lack of E␤, although the deletion in the BAC is more extended so that a possible contribution of other control elements is not excluded. We observed similar phenotypes in two independent tg lines, thus excluding effects caused by the integration site. The TCR␤ joint encoded by the transgene was cloned from the TCR␦ sf ϩ DN4 population. Although previous studies failed to confirm the existence of nonfunctional TCR␤-chains (Ref. 36; A. Rolink, unpublished observations), we considered the possibility that the TCR␤ tg does not support ␣␤ T cell development. However, the product of the transgene exhibited all three major hallmarks of a TCR␤-chain that can give rise to a functional pre-TCR. First, it was capable of mediating allelic exclusion of endogenous TCR␤ loci (35) as shown on the DNA and protein levels. Second, it is capable of facilitating ␤-selection because its introduction onto a TCR␤ Ϫ/Ϫ background alleviated the developmental block in the production of DP cells in these knockout mice (5). Third, it suppressed ␥␦ T cell development (34), a phenomenon that has been shown to be at least FIGURE 5. Allelic exclusion of endogenous TCR␤ loci in tg mice. a, PCRs for V␤4.13 J␤2 and V␤6.13 J␤2 rearrangements were performed on genomic DNA of DN3 thymocytes of WT mice, splenocytes of Rag-2 Ϫ/Ϫ mice, and V␤8.1/8.2 ic ϩ or V␤8.1/8.2 ic Ϫ DN3 thymocytes of tg mice. The arrowheads show the expected size of rearrangements of the V␤4/V␤6 segment to the indicated J␤2 segment. Usage of equivalent amounts of DNA was confirmed by serial dilution PCR using insulin-specific primers. b, Six-color FACS analysis of thymocytes from WT and tg mice. Cells were surface stained for CD4, CD8, CD25, CD44, and CD161c and intracellulary stained for TCR␤, V␤8.2, and V␤4. 1. in part caused by suppression of TCR␥ rearrangements due to early expression of a pre-TCR in DN3 (12) .
We also considered the possibility that transgene expressing cells did not survive, either due to toxicity of one of the products of the transgene or to negative selection by a putative superantigen. Toxicity was ruled out by two types of experiments. First, annexin V/PI stainings revealed no significant increase of apoptotic cells in the tg DN3 population and a decrease rather than an increase in apoptotic cells in the tg DN4 population. Second, GFP ϩ DN3 cells developed into V␤8.1/8.2 ic Ϫ DN3 and subsequently into V␤8.1/ 8.2 ic Ϫ DN4 cells in RTOCs, showing that transgene expressing cells do not die but rather shutdown expression of the transgene. Finally, transgene expressing cells are ␤-selected in vivo as they give rise to DP cells on a TCR␤ Ϫ/Ϫ background. Superantigen deletion had to be considered because the FVB mouse strain lacks an endogenous V␤8.2 segment. Therefore, it was conceivable that a retrovirally derived superantigen could mediate a strong interaction between the tg V␤8.2 chain and the endogenous H-2 q MHC molecules, resulting in deletion of the transgene-expressing cells. However, as superantigen-mediated deletions take place at the DP and not at the DN3 stage, it is unlikely that the loss of V␤8.2 ϩ cells is caused by this mechanism. In addition, loss of transgene expression was also seen in RTOCs using BALB/c-derived thymic stroma, which expresses MHC molecules of the H-2 d haplotype and supports development of V␤8.2 ϩ T cells. What is the origin of the GFP Ϫ DN3 population? As transgene expression starts in DN2 and GFP Ϫ DN3 cells do not give rise to V␤8.1/8.2 ic ϩ cells in RTOCs, it is likely that these cells may have previously expressed the transgene and have already down-regulated it, placing them at a later developmental stage than the GFP ϩ DN3 cells. On the other hand, while being in a similar developmental stage as the GFP ϩ cells, GFP Ϫ DN3 cells may never express the transgene due to mechanisms such as position effect variegation. We favor the first mechanism because of the suppression of endogenous TCR␤ VDJ rearrangements, which is equally pronounced in both the V␤8 ϩ and V␤8 Ϫ DN3 cells of tg mice. In case of the second mechanism, the GFP Ϫ cell population, which accounts for a majority of DN3 cells, should not show allelic exclusion of the endogenous TCR␤ loci. This assumption is not at variance with the small number of DN3 cells that show endogenous TCR␤ V3 DJ rearrangements. TCR␤ transgenes never cause complete suppression of endogenous TCR␤ rearrangements, presumably because tg expression in DN2 does not give rise to a pre-TCR due to lack of CD3⑀ expression in this population (10).
We envisage thymocyte development in the ⌬E␤ tg mice as consisting of two tiers, one driven by the TCR␤ tg and the other by endogenous TCR␤-chains. The tg TCR␤ is expressed in most of the DN2 cells and gives rise to the formation of a pre-TCR as soon as CD3 components are expressed in early DN3 (10), thus suppressing endogenous TCR␤ and TCR␥ rearrangements. Signals through the pre-TCR initiate ␤-selection of a large proportion of this population, driving development though the pre-TCR-dependent checkpoint into the DN4 and DP stages. Transgene expression is terminated in DN3, resulting in lack of intracellular TCR␤ in most DN4 and DP cells, as well as in premature termination of proliferation and reduced numbers of DP cells. The DP stage is the end point of most TCR␤ ic Ϫ TCR␦ ic Ϫ cells, but a minority may even proceed to the SP stage, as indicated by the TCR␤ ic Ϫ SP subset. In parallel, a few DN3 cells produce in-frame rearrangements of endogenous TCR␤ loci, express these TCR␤-chains, and develop into TCR␤ ic ϩ TCR␦ ic Ϫ DN4, DP, and SP cells, in line with the ϳ5-fold decrease in the positively selected CD69 ϩ population. Because of pre-TCR and TCR expression in this population, the TCR␤ ic ϩ cells proliferate and undergo positive selection normally, finally giving rise to ϳ50% of all SP cells.
Unexpectedly, tg mice showed an ϳ3-fold drop in the ratio of CD4:CD8 SP cells. This phenotype is reminiscent of the one seen in WT/TCR␣ Ϫ/Ϫ mixed bone marrow chimeras (37), which contain two cell populations: one that is competent of developing into the SP and one that is arrested in the DP stage. This study also reported a decreased CD4:CD8 ratio, suggesting to the investigators that the selection of CD8 SP cells in normal mice may be limited by the amount of available MHC class I molecules, whereas selection of CD4 SP cells may be limited by the generation of MHC class II-restricted TCR. This effect may also be responsible for our observations because also in ⌬E␤ tg mice only a minor proportion of DP cells are capable of maturing to the SP stage. In addition, the less pronounced reduction in CD8 SP cells may be due to ISP cells in this population.
Our study shows that E␤ is dispensable for transcription of a rearranged TCR␤ tg in the DN2/DN3 population but not at later stages of thymopoesis. In normal mice, some TCR␤ genes that rearrange in DN2 and early DN3 cells may indeed be expressed E␤ independently, but most rearrangements likely take place after E␤-dependent expression commences in DN3. Previous reports (17, 26, 27) described germline V␤ transcripts in the thymi of anti-CD3⑀-induced, E␤-deficient Rag Ϫ/Ϫ mice and interpreted this observation as E␤-independent transcription in the DP population. However, these studies did not use purified DP cells so that the results could be due to the DN cells that are still present in anti-CD3⑀-induced Rag Ϫ/Ϫ thymi. Alternatively, induction of Rag
thymocytes with anti-CD3⑀ may represent too brief a stimulus that is sufficient to drive the cells over the ␤-selection checkpoint but insufficient to induce E␤ dependence of germline transcription, a process that might require prolonged pre-TCR signaling. As a third possibility, transcription of rearranged TCR␤ genes may have different regulatory requirements than germline transcription. We have shown previously that transcription of rearranged TCR␤ genes in DN3 is subject to regulation by signaling through the CD3 complex, whereas this is not the case for later developmental stages (38, 39) . These results agree with the present data in suggesting that a drastic change takes place in the regulation of the expression of TCR␤ genes during the DN3 stage.
